Sort   by:  
 Page size 
ProteomicsBile acids at host-Enterobacteriaceae interface
The intestinal mucosa of inflammatory bowel disease (IBD) patients is enriched with Enterobacteriaceae members. Concurrently, there is elevated bile acid (BA) bioavailability in the colons of IBD patients. Whether enhanced BA levels contribute to the bloom of Enterobacteriaceae members in IBD patien...
ORGANISM(S): Homo sapiens (Human) 
2025-10-07 | PXD041934 | Pride
Enterobacteriaceae Bile acids Mitochondrial dysfunction Crohn’s disease 
UnknownThe complete spectrum of yeast chromosome instability genes identifies candidate CIN cancer genes and functional roles for ASTRA complex components.
Not available
S-EPMC3084213 | biostudies-literature
ProteomicsPhotoredox-catalyzed decarboxylative C-terminal differentiation for bulk and single molecule proteomics
Methods for the selective labeling of functional groups on peptides are being developed and used in the workflow of both current and emerging proteomics technologies, such as single-molecule fluorosequencing. Photoredox methods in discriminative targeting of the terminal carboxylic acid from the int...
ORGANISM(S): Bos Taurus (ncbitaxon:9913) Homo Sapiens (ncbitaxon:9606) Saccharomyces Cerevisiae (ncbitaxon:4932) 
2021-06-01 | MSV000087551 | MassIVE
ProteomicsMtruncatula - Flower, iBAQ (Marxetal,natbiotechnol2016)
abundance based on iBAQ, Interaction consistency score: 17.0, Coverage: 32
ORGANISM(S): 3880 
2016-00-00 | 2102073507 | PAXDB
UnknownAzithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904 | biostudies-literature
UnknownAspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213 | biostudies-literature
UnknownBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
Sort   by:  
 Page size